NCT06661655Recruiting
Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
Source: ClinicalTrials.gov · Last updated 15 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The objective of the study is to evaluate an ultraportable ultrasound device, Hepatoscope, for the non-invasive assessment of hepatic steatosis in patients with metabolic-dysfunction associated liver diseases (MASLD), by comparing its measurements with current diagnostic modalities, such as MRI-PDFF.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 24 Oct 2024
- Start date
- 24 Jul 2025
- Primary completion date
- 1 Mar 2026
- Lead sponsor
- E-Scopics
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT06661655
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 24 Jul 2025 to the primary completion date, 1 Mar 2026
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient with active implants,
Other illness
- Patient with a history of decompensated cirrhosis,
- Patient with a history of hepatocellular carcinoma,
- Patient presenting with another know liver disease
Age
- Patient in their minority (less than 18 yo) or older than 80 yo,
Other
- Patient presenting with a wound where the Hepatoscope exam shall be performed (abdominal right upper quadrant)
- Adult patient under tutorship, or unable to express informed consent,
- Pregnant or breast-feeding
- Person deprived from their liberty
- Patient hospitalized without providing consent or in case of an emergency
Who the study is looking for
- Adult patient below 80 yo
- Patients with MASLD/MASH recruited in interventional trials requiring MRI PDFF +/- MRE per interventional protocol, OR
- Patients with MASLD/MASH recruited in prospective cohorts requiring MRI PDFF +/- MRE per interventional protocol, OR
- Patients referred to MRI-PDFF or MRE.
- Patients who consented in written to participate in the study
- Patients with ongoing social security coverage
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Angers Coordinator of this site? Confirm its status | Angers | France | Recruiting |
| Beaujon University Hospital Coordinator of this site? Confirm its status | Clichy | France | Recruiting |
| Pitié-Salpêtrière University Hospital Coordinator of this site? Confirm its status | Paris | France | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.